Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital

In this research, we address the urgent need for accurate prediction of in-hospital survival periods for patients diagnosed with pancreatic cancer (PC), a disease notorious for its late-stage diagnosis and dismal survival rates. Utilizing machine learning (ML) technologies, we focus on the applicati...

Full description

Bibliographic Details
Main Authors: Yuan Wang, Chenbi Li, Zeheng Wang
Format: Article
Language:English
Published: IEEE 2024-01-01
Series:IEEE Access
Subjects:
Online Access:https://ieeexplore.ieee.org/document/10379091/
_version_ 1797361463434674176
author Yuan Wang
Chenbi Li
Zeheng Wang
author_facet Yuan Wang
Chenbi Li
Zeheng Wang
author_sort Yuan Wang
collection DOAJ
description In this research, we address the urgent need for accurate prediction of in-hospital survival periods for patients diagnosed with pancreatic cancer (PC), a disease notorious for its late-stage diagnosis and dismal survival rates. Utilizing machine learning (ML) technologies, we focus on the application of Variational Autoencoders (VAE) for data augmentation and ensemble learning techniques for enhancing predictive accuracy. Our dataset comprises biochemical blood test (BBT) results from stage II/III PC patients, which is limited in size, making VAE’s capability for data augmentation particularly valuable. The study employs several ML models, including Elastic Net (EN), Decision Trees (DT), and Radial Basis Function Support Vector Machine (RBF-SVM), and evaluates their performance using metrics such as Mean Absolute Error (MAE) and Mean Squared Error (MSE). Our findings reveal that EN, DT, and RBF-SVM are the most effective models within a VAE-augmented framework, showing substantial improvements in predictive accuracy. An ensemble learning approach further optimized the results, reducing the MAE to approximately 10 days. These advancements hold significant implications for the field of precision medicine, enabling more targeted therapeutic interventions and optimizing healthcare resource allocation. The study can also serve as a foundational step towards more personalized and effective healthcare solutions for PC patients.
first_indexed 2024-03-08T15:55:03Z
format Article
id doaj.art-dfd9e55b1a3f4a858aa4e6f1a1ad7647
institution Directory Open Access Journal
issn 2169-3536
language English
last_indexed 2024-03-08T15:55:03Z
publishDate 2024-01-01
publisher IEEE
record_format Article
series IEEE Access
spelling doaj.art-dfd9e55b1a3f4a858aa4e6f1a1ad76472024-01-09T00:04:16ZengIEEEIEEE Access2169-35362024-01-01123428343610.1109/ACCESS.2023.334881010379091Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local HospitalYuan Wang0Chenbi Li1Zeheng Wang2https://orcid.org/0000-0002-6994-1234Department of Oncology, 3201 Hospital, Hanzhong, ChinaDepartment of ICU, 3201 Hospital, Hanzhong, ChinaData61, CSIRO, Clayton, VIC, AustraliaIn this research, we address the urgent need for accurate prediction of in-hospital survival periods for patients diagnosed with pancreatic cancer (PC), a disease notorious for its late-stage diagnosis and dismal survival rates. Utilizing machine learning (ML) technologies, we focus on the application of Variational Autoencoders (VAE) for data augmentation and ensemble learning techniques for enhancing predictive accuracy. Our dataset comprises biochemical blood test (BBT) results from stage II/III PC patients, which is limited in size, making VAE’s capability for data augmentation particularly valuable. The study employs several ML models, including Elastic Net (EN), Decision Trees (DT), and Radial Basis Function Support Vector Machine (RBF-SVM), and evaluates their performance using metrics such as Mean Absolute Error (MAE) and Mean Squared Error (MSE). Our findings reveal that EN, DT, and RBF-SVM are the most effective models within a VAE-augmented framework, showing substantial improvements in predictive accuracy. An ensemble learning approach further optimized the results, reducing the MAE to approximately 10 days. These advancements hold significant implications for the field of precision medicine, enabling more targeted therapeutic interventions and optimizing healthcare resource allocation. The study can also serve as a foundational step towards more personalized and effective healthcare solutions for PC patients.https://ieeexplore.ieee.org/document/10379091/Pancreatic cancermachine learningbioinformaticssmall-scale datavariational auto-encoder
spellingShingle Yuan Wang
Chenbi Li
Zeheng Wang
Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
IEEE Access
Pancreatic cancer
machine learning
bioinformatics
small-scale data
variational auto-encoder
title Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
title_full Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
title_fullStr Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
title_full_unstemmed Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
title_short Advancing Precision Medicine: VAE Enhanced Predictions of Pancreatic Cancer Patient Survival in Local Hospital
title_sort advancing precision medicine vae enhanced predictions of pancreatic cancer patient survival in local hospital
topic Pancreatic cancer
machine learning
bioinformatics
small-scale data
variational auto-encoder
url https://ieeexplore.ieee.org/document/10379091/
work_keys_str_mv AT yuanwang advancingprecisionmedicinevaeenhancedpredictionsofpancreaticcancerpatientsurvivalinlocalhospital
AT chenbili advancingprecisionmedicinevaeenhancedpredictionsofpancreaticcancerpatientsurvivalinlocalhospital
AT zehengwang advancingprecisionmedicinevaeenhancedpredictionsofpancreaticcancerpatientsurvivalinlocalhospital